NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html
This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics.
Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.
1: Research Objectives, Method Details, and Segmentation
1.1: Research Objectives and Method Details
Table 1: Research Objectives and Method Details
1.2: Segmentation
2: Executive Summary
2.1: Patient Compliance to Eye Care Medications
2.2: Factors Impacting Eye Care Medication Prescriptions
2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications
Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications
3: Patient Compliance with Eye Care Medications
3.1: Assessment of Patient Compliance
3.2: Analyst Comments
3.3: Average Number of Medications Taken by Glaucoma Patients
4: Factors Impacting Prescriptions of Eye Care Medications
4.1: Eye Care Medications: Most Important Features
4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications
4.3: Patients' Involvement in Eye Care Medication Selection Process
5: Preferences for Glaucoma Medications
5.1: Prostaglandin Analogues for Glaucoma
5.1.1: Primary Brand Use and Brand Reputation
5.1.2: Brand Loyalty
5.2: Beta Blockers for Glaucoma
5.2.1: Primary Brand Use and Brand Reputation
5.2.2: Brand Loyalty
5.3: Combination Therapies for Glaucoma
5.3.1: Primary Brand Use and Brand Reputation
5.3.2: Brand Loyalty
5.4: Carbonic Anhydrase Inhibitors for Glaucoma
5.4.1: Primary Brand Use and Brand Reputation
5.4.2: Brand Loyalty
5.5: Alpha Adrenergic Agonists for Glaucoma
5.5.1: Primary Brand Use and Brand Reputation
6: Preferences for Other Eye Disease Medications
6.1: Age-Related Macular Degeneration Medications
6.1.1: Primary Brand Use and Brand Reputation
6.1.2: Brand Loyalty
6.1.3: Lucentis Versus Avastin
6.2: Allergic Conjunctivitis Medications
6.2.1: Primary Brand Use and Brand Reputation
6.2.2: Brand Loyalty
6.3: NSAID Medications
6.3.1: Primary Brand Use and Brand Reputation
6.3.2: Brand Loyalty
7: Appendices
7.1: Preferences for Glaucoma Medications
7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.2: Preferences for Other Eye Disease Medications
7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments
7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments
7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments
To order this report:
Drug and Medication Industry:
Drug and Medication Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html
This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics.
Advertisement
Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.
1: Research Objectives, Method Details, and Segmentation
1.1: Research Objectives and Method Details
Table 1: Research Objectives and Method Details
1.2: Segmentation
2: Executive Summary
2.1: Patient Compliance to Eye Care Medications
2.2: Factors Impacting Eye Care Medication Prescriptions
2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications
Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications
3: Patient Compliance with Eye Care Medications
3.1: Assessment of Patient Compliance
3.2: Analyst Comments
3.3: Average Number of Medications Taken by Glaucoma Patients
4: Factors Impacting Prescriptions of Eye Care Medications
4.1: Eye Care Medications: Most Important Features
4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications
4.3: Patients' Involvement in Eye Care Medication Selection Process
5: Preferences for Glaucoma Medications
5.1: Prostaglandin Analogues for Glaucoma
5.1.1: Primary Brand Use and Brand Reputation
5.1.2: Brand Loyalty
5.2: Beta Blockers for Glaucoma
5.2.1: Primary Brand Use and Brand Reputation
5.2.2: Brand Loyalty
5.3: Combination Therapies for Glaucoma
5.3.1: Primary Brand Use and Brand Reputation
5.3.2: Brand Loyalty
5.4: Carbonic Anhydrase Inhibitors for Glaucoma
5.4.1: Primary Brand Use and Brand Reputation
5.4.2: Brand Loyalty
5.5: Alpha Adrenergic Agonists for Glaucoma
5.5.1: Primary Brand Use and Brand Reputation
6: Preferences for Other Eye Disease Medications
6.1: Age-Related Macular Degeneration Medications
6.1.1: Primary Brand Use and Brand Reputation
6.1.2: Brand Loyalty
6.1.3: Lucentis Versus Avastin
6.2: Allergic Conjunctivitis Medications
6.2.1: Primary Brand Use and Brand Reputation
6.2.2: Brand Loyalty
6.3: NSAID Medications
6.3.1: Primary Brand Use and Brand Reputation
6.3.2: Brand Loyalty
7: Appendices
7.1: Preferences for Glaucoma Medications
7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments
7.2: Preferences for Other Eye Disease Medications
7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments
7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments
7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments
To order this report:
Drug and Medication Industry:
Drug and Medication Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
